Canmab 440 mg Injection
  1. Home
  2. Pharma Products
  3. Biocon
  4. Canmab 440 mg Injection

Canmab 440 mg Injection

Canmab 440 mg Injection contains trastuzumab, a targeted monoclonal antibody used for certain HER2-positive cancers. It is mainly used for HER2-positive breast cancer and certain stomach cancers. The medicine works by targeting the HER2 protein and slowing the growth of cancer cells.

BUY NOW

Category

Canmab 440 mg Injection is administered by intravenous infusion under qualified medical supervision. Trastuzumab specifically binds to HER2 receptors on cancer cells and helps inhibit their growth and survival. The 440 mg presentation is supplied as a lyophilized powder and requires reconstitution with the supplied diluent before administration. Treatment requires monitoring for infusion reactions and cardiac function during therapy.

 

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 440 mg
Dosage Form Lyophilized Powder for Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial
Manufacturer Biocon Ltd

Product Also Known As

Canmab 440 mg Injection, Trastuzumab 440 mg Injection, Canmab Trastuzumab Injection, Trastuzumab HER2 Therapy, HER2 Positive Cancer Injection, Breast Cancer Targeted Therapy Injection